Upgrade to SI Premium - Free Trial

UBS Upgrades Celestica (CLS) to Buy

August 24, 2026 12:42 AM
UBS analyst David Vogt upgraded Celestica (NYSE: CLS) from Neutral to Buy with a price target of $430.00 (from $410.00).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades